How many FDA warning letters has PAYLESS COMPOUNDERS, LLC received?

Argus HQ has not recorded an FDA warning letter for PAYLESS COMPOUNDERS, LLC in our current dataset.

What FDA recalls has PAYLESS COMPOUNDERS, LLC issued?

Argus HQ has recorded 1 FDA recall tied to PAYLESS COMPOUNDERS, LLC.

Is PAYLESS COMPOUNDERS, LLC FDA compliant?

Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 1 recall, and 0 approval records for PAYLESS COMPOUNDERS, LLC. Review the linked FDA source records directly before drawing a compliance conclusion.

.hq

company

PAYLESS COMPOUNDERS, LLC

Name: FDA Enforcement Actions Against PAYLESS COMPOUNDERS, LLC
Creator: Argus HQ
License: https://argushq.ai/methodology

Jurisdiction: US

FDA Warning Letter timeline

V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.

fda_recall · drug_recall2026-04-22
PAYLESS COMPOUNDERS, LLC — Class II recall: Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL via…

Frequently asked questions

How many FDA warning letters has PAYLESS COMPOUNDERS, LLC received?: Argus HQ has not recorded an FDA warning letter for PAYLESS COMPOUNDERS, LLC in our current dataset.
What FDA recalls has PAYLESS COMPOUNDERS, LLC issued?: Argus HQ has recorded 1 FDA recall tied to PAYLESS COMPOUNDERS, LLC.
Is PAYLESS COMPOUNDERS, LLC FDA compliant?: Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 1 recall, and 0 approval records for PAYLESS COMPOUNDERS, LLC. Review the linked FDA source records directly before drawing a compliance conclusion.

Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.